Gapping up
In reaction to strong earnings/guidance: WBMD +5.4%, C +2%.
M&A news: NBS +13% ( to acquire California Stem Cell; agreement provides for the issuance of an aggregate of up to ~ 5.33 mln shares of NBS common stock in exchange for all of the CSC outstanding stock and options), CHDX halted (Chindex Announces Receipt of Superior Proposal to acquire all of the outstanding shares of Chindex common stock for $23 per share in cash).
Select financial related names showing strength boosted by C results: MS +1.8% (modestly higher following C results and on reports that the co may divest Learning Care unit in near term), WFC +1.5%, GS +1.0%, USB +0.9%, JPM +0.5% (Barron's profiles positive view on JP Morgan), .
Select metals/mining stocks trading higher: HMY +2.5%, GOLD +2.2%, GG +2.1%, ABX +1% .
European consumer discretionary names trading higher: DEO +3.1% BUD +1.8% and UL +1.8%, UN +1.4% .
Other news: LXRX +19.5% (announces positive, top-line results in a Phase 2 clinical trial of LX4211 in type 1 diabetes, which achieved the primary endpoint of reducing mealtime insulin use as well as several secondary endpoints, including improved glycemic control ), MSTX +16.4% (announces new data supporting MST-188 In Sickle Cell Disease; MST-188 decreased a marker of inflammation and red blood cell aggregation), HTM +15.6% ( has acquired geothermal property for evaluation of a new project at Vale, Oregon), EW +12.4% (Federal Court orders preliminary injunction on U.S. Sales of Medtronic's infringing Transcatheter Valve; Edwards Lifesciences upgraded to Neutral from Underweight at JP Morgan), GDP +8.7% (announces completion of its Blades 33H-1 (66.7% WI) well in Tangipahoa Parish, Louisiana; well has achieved a peak 24-hour average production rate to date of 1,270 BOE per day, comprised of 1,250 barrels of oil and 115 Mcf of gas on a 14/64 inch choke from an ~ 5,000 foot lateral), CYTX +6.7% ( announces publication of safety and efficacy data from a 36 month European clinical trial of Cytori Cell Therapy in patients with chronic ischemic heart failure; PRECISE data demonstrate sustained safety and benefit and 18 months), JASO +4.6% (expects total shipment volume in the first quarter of 2014 to exceed 620 MW, ahead of its previously announced guidance of 580 MW to 610 MW), RDNT +3.2% (still checking), ICPT +2.3% (reports additional positive data from POISE Trial at EASL late-breaker session), RAD+2.3% (positive comments on Friday's Mad Money), DDD +1.9% (announced a partnership with Staples in a pilot of 3D printing services in two Staples stores in New York City and Los Angeles; initiated with a Neutral at Goldman; tgt $63), S +1.8% (Sprint and Spotify plan streaming music partnership, according to reports ), JCP +1.3% (still checking), HLF +0.8% (following late sell-off on reports of criminal investigation), VNO +0.5% (discloses spin off of its shopping center business), TOT +0.5% (Total and its JV partners launch development of Kaombo, an ultra-deep offshore project).
Analyst comments:AKBA +14.5% (initiated by several analysts), STX +4% (upgraded at Argus), BSX +2.4% (upgraded to Buy from Neutral at BofA/Merrill), PANW +2.2% (upgraded to Overweight from Equal Weight at Barclays), SSYS +2% (initiated with a Buy at Goldman; tgt $146), YHOO +1.6% (Yahoo upgraded to Buy from Neutral at SunTrust), MA +1.2% ( upgraded to Outperform at Robert W. Baird), V +0.7% (upgraded to Outperform at Robert W. Baird ), RIG +0.6% (upgraded to Hold from Sell at Deutsche Bank),
M&A news: NBS +13% ( to acquire California Stem Cell; agreement provides for the issuance of an aggregate of up to ~ 5.33 mln shares of NBS common stock in exchange for all of the CSC outstanding stock and options), CHDX halted (Chindex Announces Receipt of Superior Proposal to acquire all of the outstanding shares of Chindex common stock for $23 per share in cash).
Select financial related names showing strength boosted by C results: MS +1.8% (modestly higher following C results and on reports that the co may divest Learning Care unit in near term), WFC +1.5%, GS +1.0%, USB +0.9%, JPM +0.5% (Barron's profiles positive view on JP Morgan), .
Select metals/mining stocks trading higher: HMY +2.5%, GOLD +2.2%, GG +2.1%, ABX +1% .
European consumer discretionary names trading higher: DEO +3.1% BUD +1.8% and UL +1.8%, UN +1.4% .
Other news: LXRX +19.5% (announces positive, top-line results in a Phase 2 clinical trial of LX4211 in type 1 diabetes, which achieved the primary endpoint of reducing mealtime insulin use as well as several secondary endpoints, including improved glycemic control ), MSTX +16.4% (announces new data supporting MST-188 In Sickle Cell Disease; MST-188 decreased a marker of inflammation and red blood cell aggregation), HTM +15.6% ( has acquired geothermal property for evaluation of a new project at Vale, Oregon), EW +12.4% (Federal Court orders preliminary injunction on U.S. Sales of Medtronic's infringing Transcatheter Valve; Edwards Lifesciences upgraded to Neutral from Underweight at JP Morgan), GDP +8.7% (announces completion of its Blades 33H-1 (66.7% WI) well in Tangipahoa Parish, Louisiana; well has achieved a peak 24-hour average production rate to date of 1,270 BOE per day, comprised of 1,250 barrels of oil and 115 Mcf of gas on a 14/64 inch choke from an ~ 5,000 foot lateral), CYTX +6.7% ( announces publication of safety and efficacy data from a 36 month European clinical trial of Cytori Cell Therapy in patients with chronic ischemic heart failure; PRECISE data demonstrate sustained safety and benefit and 18 months), JASO +4.6% (expects total shipment volume in the first quarter of 2014 to exceed 620 MW, ahead of its previously announced guidance of 580 MW to 610 MW), RDNT +3.2% (still checking), ICPT +2.3% (reports additional positive data from POISE Trial at EASL late-breaker session), RAD+2.3% (positive comments on Friday's Mad Money), DDD +1.9% (announced a partnership with Staples in a pilot of 3D printing services in two Staples stores in New York City and Los Angeles; initiated with a Neutral at Goldman; tgt $63), S +1.8% (Sprint and Spotify plan streaming music partnership, according to reports ), JCP +1.3% (still checking), HLF +0.8% (following late sell-off on reports of criminal investigation), VNO +0.5% (discloses spin off of its shopping center business), TOT +0.5% (Total and its JV partners launch development of Kaombo, an ultra-deep offshore project).
Analyst comments:AKBA +14.5% (initiated by several analysts), STX +4% (upgraded at Argus), BSX +2.4% (upgraded to Buy from Neutral at BofA/Merrill), PANW +2.2% (upgraded to Overweight from Equal Weight at Barclays), SSYS +2% (initiated with a Buy at Goldman; tgt $146), YHOO +1.6% (Yahoo upgraded to Buy from Neutral at SunTrust), MA +1.2% ( upgraded to Outperform at Robert W. Baird), V +0.7% (upgraded to Outperform at Robert W. Baird ), RIG +0.6% (upgraded to Hold from Sell at Deutsche Bank),